Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,465,530
+$552,571 QoQ
Shares Held
41,446
+27.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $28,683,243 across 18 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
168,475 | $5,074,466 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
219,025 | $4,546,958 | |
| 3 | ZTS |
Zoetis Inc.
|
37,512 | $4,434,293 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
461,432 | $2,491,732 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
39,735 | $1,913,239 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
|
689,874 | $1,890,254 | |
| 7 | ALKS |
Alkermes plc.
This page
|
41,446 | $1,465,530 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
44,815 | $1,365,961 |
All Filings in ALKS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,465,530 | 41,446 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $912,959 | 32,629 | Shares | Defined | 2026-02-17 | |
| 2024-12-31 | $452,653 | 15,739 | Shares | Defined | 2025-02-13 | |
| 2023-09-30 | $468,915 | 16,741 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $7,312,055 | 233,612 | Shares | Sole | 2023-08-07 | |
| 2022-12-31 | $2,918,433 | 111,689 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,363,969 | 150,648 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $4,728,268 | 158,720 | Shares | Sole | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||